Circulating endocannabinoidome signatures of disease activity in amyotrophic lateral sclerosis
{{output}}
Background and purpose: Preclinical studies of amyotrophic lateral sclerosis (ALS) have shown altered endocannabinoid (eCB) signalling that may contribute to the disease. Results from human studies are sparse and inconclusive. Th... ...
